PD-L1 amplification occurs only in a small subset of malignancies, such as oral squamous cell carcinoma [177], non-small cell lung cancer [178], cervical squamous cell carcinoma [179], and triple-negative breast cancer [180]. Here, CD274 is linked to triple-negative breast carcinoma.